Iambic Therapeutics sets IPO at $15-$17 per share
Iambic Therapeutics plans to sell nearly 9.4 million shares in its IPO at $15-$17 each, targeting about $135 million in net proceeds at the $16 midpoint.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.